AAAAAA
Results: 1-25/30
Authors:
Choi, SJ
Han, JH
Roodman, GD
Citation: Sj. Choi et al., ADAM8: A novel osteoclast stimulating factor, J BONE MIN, 16(5), 2001, pp. 814-822
Authors:
Choi, SJ
Kurihara, N
Oba, Y
Roodman, GD
Citation: Sj. Choi et al., Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment, J BONE MIN, 16(10), 2001, pp. 1804-1811
Authors:
Roodman, GD
Citation: Gd. Roodman, Biology of osteoclast activation in cancer, J CL ONCOL, 19(15), 2001, pp. 3562-3571
Authors:
Cruz, JC
Alsina, M
Craig, F
Yoneda, T
Anderson, JL
Dallas, M
Roodman, GD
Citation: Jc. Cruz et al., Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma, EXP HEMATOL, 29(4), 2001, pp. 441-447
Authors:
Roodman, GD
Citation: Gd. Roodman, Studies in Paget's disease and their relevance to oncology, SEMIN ONCOL, 28(4), 2001, pp. 15-21
Authors:
Callander, NS
Roodman, GD
Citation: Ns. Callander et Gd. Roodman, Myeloma bone disease, SEM HEMATOL, 38(3), 2001, pp. 276-285
Authors:
Leach, RJ
Singer, FR
Roodman, GD
Citation: Rj. Leach et al., Genetics of endocrine disease - The genetics of Paget's disease of the bone, J CLIN END, 86(1), 2001, pp. 24-28
Authors:
Reddy, SV
Kurihara, N
Menaa, C
Landucci, G
Forthal, D
Koop, BA
Windle, JJ
Roodman, GD
Citation: Sv. Reddy et al., Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts, ENDOCRINOL, 142(7), 2001, pp. 2898-2905
Authors:
Dhodapkar, MV
Jacobson, JL
Gertz, MA
Rivkin, SE
Roodman, GD
Tuscano, JM
Shurafa, M
Kyle, RA
Crowley, JJ
Barlogie, B
Citation: Mv. Dhodapkar et al., Prognostic factors and response to fludarabine therapy in patients with Waldenstrom macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003), BLOOD, 98(1), 2001, pp. 41-48
Authors:
Han, JH
Choi, SJ
Kurihara, N
Koide, M
Oba, Y
Roodman, GD
Citation: Jh. Han et al., Macrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappa B ligand, BLOOD, 97(11), 2001, pp. 3349-3353
Authors:
Hentunen, TA
Choi, SJ
Boyce, BF
Dallas, MR
Dallas, SL
Shen-Ong, GL
Roodman, GD
Citation: Ta. Hentunen et al., A murine model of inflammatory bone disease, BONE, 26(2), 2000, pp. 183-188
Authors:
Rha, SY
Izbicka, E
Lawrence, R
Davidson, K
Sun, DK
Moyer, MP
Roodman, GD
Hurley, L
Von Hoff, D
Citation: Sy. Rha et al., Effect of telomere and telomerase interactive agents on human tumor and normal cell lines, CLIN CANC R, 6(3), 2000, pp. 987-993
Authors:
Menaa, C
Barsony, J
Reddy, SV
Cornish, J
Cundy, T
Roodman, GD
Citation: C. Menaa et al., 1,25-dihydroxyvitamin D-3 hypersensitivity of osteoclast precursors from patients with Paget's disease, J BONE MIN, 15(2), 2000, pp. 228-236
Authors:
Whyte, MP
Mills, BG
Reinus, WR
Podgornik, MN
Roodman, GD
Gannon, FH
Eddy, MC
McAlister, WH
Citation: Mp. Whyte et al., Expansile skeletal hyperphosphatasia: A new familial metabolic bone disease, J BONE MIN, 15(12), 2000, pp. 2330-2344
Authors:
Schaub, R
Dupont, B
Roodman, GD
Leach, RJ
Reddy, SV
Citation: R. Schaub et al., Assignment of OSTF1 to human chromosome bands 12q24.1 -> q24.2 by in situ hybridization, CYTOG C GEN, 88(1-2), 2000, pp. 87-88
Authors:
Kurihara, N
Reddy, SV
Menaa, C
Anderson, D
Roodman, GD
Citation: N. Kurihara et al., Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype, J CLIN INV, 105(5), 2000, pp. 607-614
Authors:
Menaa, C
Reddy, SV
Kurihata, N
Maeda, H
Anderson, D
Cundy, T
Cornish, J
Singer, FR
Bruder, JM
Roodman, GD
Citation: C. Menaa et al., Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone, J CLIN INV, 105(12), 2000, pp. 1833-1838
Authors:
Choi, SJ
Cruz, JC
Craig, F
Chung, H
Devlin, RD
Roodman, GD
Alsina, M
Citation: Sj. Choi et al., Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma, BLOOD, 96(2), 2000, pp. 671-675
Authors:
Menaa, C
Kurihara, N
Roodman, GD
Citation: C. Menaa et al., CFU-GM-derived cells form osteoclasts at a very high efficiency, BIOC BIOP R, 267(3), 2000, pp. 943-946
Authors:
Roodman, GD
Citation: Gd. Roodman, Mechanisms of abnormal bone turnover in Paget's disease, BONE, 24(5), 1999, pp. 39S-40S
Authors:
Wirfel, KL
Bruder, JM
Vardag, A
Roodman, GD
Citation: Kl. Wirfel et al., Osteoclast function in healthy subjects and in patients with Paget's disease, ENDOCRINOLO, 9(4), 1999, pp. 263-269
Authors:
Reddy, SV
Menaa, C
Singer, FR
Demulder, A
Roodman, GD
Citation: Sv. Reddy et al., Cell biology of Paget's disease, J BONE MIN, 14, 1999, pp. 3-8
Authors:
Leach, RJ
Singer, FR
Cody, JD
Roodman, GD
Citation: Rj. Leach et al., Variable disease severity associated with a Paget's disease predispositiongene, J BONE MIN, 14, 1999, pp. 17-20
Authors:
Roodman, GD
Citation: Gd. Roodman, Cell biology of the osteoclast, EXP HEMATOL, 27(8), 1999, pp. 1229-1241
Authors:
Reddy, SV
Menaa, C
Singer, FR
Cundy, T
Cornish, J
Whyte, MP
Roodman, GD
Citation: Sv. Reddy et al., Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone, EXP HEMATOL, 27(10), 1999, pp. 1528-1532